| |
February 2001
Although this year's influenza season is not yet through the
halfway mark, it appears so far that we may have lucked out this year.
Virtually all of the influenza viruses isolated in the United States during the
current season have been influenza A(H1N1) or influenza B, one or the other
strain predominating depending on the geographic region of the country; there
have been only a handful of influenza A(H3N2) isolates. After four consecutive
years of epidemic influenza A(H3N2), we were due for a break!
Both the influenza A(H1N1) and the influenza B isolates are well
covered by the strains in the current vaccine. Neither influenza A(H1N1) nor
influenza B has historically been associated with significant excess mortality,
and no excess mortality has been documented this far in the current season.
There have been pockets of high level school and industrial absenteeism, to be
sure, but on balance this has been a mild to moderate influenza season.
![[bar]](../art/gradient.gif) Vaccine supply
Influenza vaccine by this time is available in good supply. It now
seems a bit ironic, in retrospect, that all the pleading from the ACIP to allow
the elderly and other high-risk folks to be immunized first (when vaccine was
in short supply) was not only unheeded but also probably unnecessary, at least
in retrospect. What is clear is that the public confidence in immunization
programs has taken another "hit." After years of public education leading to
acceptance and even expectation of influenza vaccine, I suspect that overall
vaccine use this year will be sharply lower than previous years, and it may
take some years of meeting expectations for public confidence in influenza
immunization to reach previous levels.
As I alluded to two months ago, another action to be taken as a
result of this year's problems is a full investigation of the vaccine
distribution system in this country; does it need more control, especially in
the event of a threatened influenza pandemic?
![[bar]](../art/gradient.gif) Grandma's remedy
Meanwhile, as we in infectious diseases continue to explore new
approaches to influenza immunization and new neuraminidase-inhibiting drugs,
our brothers and sisters in the discipline of pulmonary diseases were also busy
investigating the therapeutic potential of another well-known remedy - chicken
soup! In a paper that is best described as a cross between serious science and
a complete spoof, Barbara Rennard and her colleagues in the pulmonary and
critical care section, Nebraska Medical Center in Omaha showed that chicken
soup inhibits neutrophil chemotaxis in vitro (CHEST 2000; 118:
1150-57). After brief discussion of the historical background and possible
beneficial effects of chicken soup, these investigators sought to evaluate the
possibility that chicken soup had some kind of attenuating effect on the immune
response.
They identified and prepared a traditional chicken soup,
identified only as "Grandma's soup," and obtained 19 samples at various stages
in the preparation process. These samples were then tested for their ability to
inhibit neutrophil chemotaxis in a standard assay using a Boyden blindwell
chemotaxis chamber, and using two different chemoattractants, zymosan-activated
serum, and fMet-Leu-Phe. The results showed a clear and significant inhibition
of chemotaxis that was concentration-dependent, and interestingly, seemingly
limited to the non-particulate part of the soup. The soup itself was not
cytotoxic, hence the inhibition of chemotaxis could not be explained on that
basis.
The investigators went on to examine 13 other commercially
available chicken soup products, at identical dilutions, and found that there
was wide variation in inhibition of chemotaxis. Indeed, five products were more
potent inhibitors than "Grandma's soup;" others were less to far less active.
The investigators carefully pointed out that Omaha tap water had no activity!
Thus, they concluded that their study is evidence that chicken soup has
anti-inflammatory activity, although they could not identify the active
ingredient(s) responsible for this activity. What happens to the
inflammatory/immune response when one actually ingests chicken soup is
unknown as this was purely an in vitro study!
Several other issues were raised in the discussion. Some hazards
of chicken soup have been reported previously, including anaphylaxis,
aspiration, including aspiration of chicken bone, and hypernatremia. None of
these seem to be especially surprising, and are based on known mechanisms. If,
however, there is an in vivo suppression of neutrophil chemotaxis (which has
never been demonstrated), one could theoretically increase the risk of
secondary infection. (For whatever it may be worth, the source of financial
support for this study was not identified!)
![[bar]](../art/gradient.gif) Naturally beneficial
In a delightful accompanying editorial, quaintly entitled
"Barbara, what's a nice girl like you doing writing an article like this?"
(CHEST 2000; 118: 887-8), Bradley Bender of the University of
Florida took a rather light-hearted approach to this work. He wrote that
chicken soup, historically, appears to be an ideal remedy for several reasons.
First, it is generally consumed sitting down, thus enforcing some rest period
from normal activity. Furthermore, if the soup is prepared in a traditional
"grandmother" fashion, additional down time is assured. Second, inhaling the
warm steam raises the temperature of the airways and assists in loosening
secretions. Finally, since the soup contains a large amount of liquid,
hydration is well maintained. All these effects are distinctly beneficial, even
absent any effect on the host immune response!
Thus, the definitive study of chicken soup remains to be carried
out! As Bender points out, one approach would be to measure neutrophil
chemotaxis in a group of volunteers in a fasting state, feed them chicken soup,
and then repeat the chemotaxis studies. Even better, use experimentally
infected subjects in such a study! He concludes: "Volunteers for this study
should form a line behind me."
And then - who knows - perhaps there might eventually prove to be
a synergistic effect of chicken soup and neuraminidase inhibitors! |